ARCHIVES

DCE Board Approves Two New Grant Programs, New Contract, Recompetitions Totaling $22 Mil.

This article is from The Cancer Letter archive.

Vol. 16 No. 10 | March 9, 1990

Download PDF Visit The Full Archive

Related Articles

Investigational Drug Radium-223 Chloride Improved Overall Survival By 44 Percent

September 30, 2011

NIH Funding Strategies, UICC Fellowships

December 4, 1992

Gene Therapy Shows Positive Results In Phase III Trial

July 25, 2008

NCI Advisory Groups To Be Cut By One-Third

April 22, 1977

Appeals Court Finds Terminally Ill Patients Have Constitutional Right To Phase I Drugs.

May 5, 2006

The Tivozanib Timeline

May 10, 2013